Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Mitsuyasu

Showing results (21-30 of 36) with videos related to

Pageof 4
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1987
Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicityJ D Katz, R Mitsuyasu, M S Gottlieb, et al.
Annales De L'Institut Pasteur. Immunology|March 1, 1987
Immune pathogenesis of AIDS and related syndromesJ L Fahey, J Giorgi, O Martínez-Maza, et al.
The Journal of Clinical Investigation|October 1, 1986
Designed transfer of specific immune responses with bone marrow transplantationA Saxon, R Mitsuyasu, R Stevens, et al.
Lancet (London, England)|August 18, 1984
Prophylaxis of Pneumocystis carinii infection in AIDS with pyrimethamine-sulfadoxineM S Gottlieb, S Knight, R Mitsuyasu, et al.
The EMBO Journal|March 1, 1989
Human immunodeficiency virus type 1 LTR TATA and TAR region sequences required for transcriptional regulationJ A Garcia, D Harrich, E Soultanakis, et al.
AIDS (London, England)|April 24, 2001
Effect of IL-2 therapy on plasma hepatitis C virus-RNA levels in HIV/hepatitis C virus co-infected patientsH Valdez, J A Metcalf, B M Gripshover, et al.
Cytokines, Cellular & Molecular Therapy|April 29, 1998
Open-label phase I study of combination therapy with zidovudine and interferon-beta in patients with AIDS-related Kaposi's sarcoma: AIDS Clinical Trials Group Protocol 057S Miles, A Levine, M Feldstein, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1989
Soluble IL-2 receptor in AIDS. Correlation of its serum level with the classification of HIV-induced diseases and its characterizationM Honda, K Kitamura, K Matsuda, et al.
Journal of Clinical Immunology|January 1, 1987
Alterations in cytotoxic and phenotypic subsets of natural killer cells in acquired immune deficiency syndrome (AIDS)S Plaeger-Marshall, C A Spina, J V Giorgi, et al.
The National Medical Journal of India|March 26, 2010
Continuing medical education on antiretroviral therapy in HIV/AIDS in India: needs assessment and impact on clinicians and allied health personnelS K Kabra, Aparna Mukherjee, S A Vani, et al.
Pageof 4

Showing results (21-30 of 36) with videos related to

Sort By:
Pageof 4
Journal of Immunology (Baltimore, Md. : 1950)|July 1, 1987
Mechanism of defective NK cell activity in patients with acquired immunodeficiency syndrome (AIDS) and AIDS-related complex. II. Normal antibody-dependent cellular cytotoxicity (ADCC) mediated by effector cells defective in natural killer (NK) cytotoxicityJ D Katz, R Mitsuyasu, M S Gottlieb, et al.
Annales De L'Institut Pasteur. Immunology|March 1, 1987
Immune pathogenesis of AIDS and related syndromesJ L Fahey, J Giorgi, O Martínez-Maza, et al.
The Journal of Clinical Investigation|October 1, 1986
Designed transfer of specific immune responses with bone marrow transplantationA Saxon, R Mitsuyasu, R Stevens, et al.
Lancet (London, England)|August 18, 1984
Prophylaxis of Pneumocystis carinii infection in AIDS with pyrimethamine-sulfadoxineM S Gottlieb, S Knight, R Mitsuyasu, et al.
The EMBO Journal|March 1, 1989
Human immunodeficiency virus type 1 LTR TATA and TAR region sequences required for transcriptional regulationJ A Garcia, D Harrich, E Soultanakis, et al.
AIDS (London, England)|April 24, 2001
Effect of IL-2 therapy on plasma hepatitis C virus-RNA levels in HIV/hepatitis C virus co-infected patientsH Valdez, J A Metcalf, B M Gripshover, et al.
Cytokines, Cellular & Molecular Therapy|April 29, 1998
Open-label phase I study of combination therapy with zidovudine and interferon-beta in patients with AIDS-related Kaposi's sarcoma: AIDS Clinical Trials Group Protocol 057S Miles, A Levine, M Feldstein, et al.
Journal of Immunology (Baltimore, Md. : 1950)|June 15, 1989
Soluble IL-2 receptor in AIDS. Correlation of its serum level with the classification of HIV-induced diseases and its characterizationM Honda, K Kitamura, K Matsuda, et al.
Journal of Clinical Immunology|January 1, 1987
Alterations in cytotoxic and phenotypic subsets of natural killer cells in acquired immune deficiency syndrome (AIDS)S Plaeger-Marshall, C A Spina, J V Giorgi, et al.
The National Medical Journal of India|March 26, 2010
Continuing medical education on antiretroviral therapy in HIV/AIDS in India: needs assessment and impact on clinicians and allied health personnelS K Kabra, Aparna Mukherjee, S A Vani, et al.
Pageof 4